Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

ACST Stock Annual Income Statement. Download in Excel

Acasti Pharma Inc. logo

Acasti Pharma Inc.

Sector: Healthcare   

Industry: Biotechnology

3.37
 
USD
  
-0.03
  
(-0.88%)
Previous close: 3.4  Open: 3.54  Bid:   Ask:
52 week range    
1.98   
   3.60
Mkt Cap: 33 M  Avg Vol (90 Days): 29,531
Peers   
OPHLY / 
ONCX / 
Last updated: Monday 4th November 2024

Stock Rankings

69
Technical
21
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

ACST Income Statement

Annual
Invalid dateMar-20Mar-21Mar-22Mar-23Mar-24
Basic EPS from continuing operations-2.4-10640.0-0.27-0.95-1.35
Basic EPS total-2.4-10640.0-0.27-0.95-1.35
Basic weighted shares outstanding11 M1,854 M37 M45 M10 M
Cost of sales76000.0
Depreciation8000.0
Depreciation unreconciled8000.0
DepreciationAndAmortization8000.0
Diluted EPS total-2.4-10640.0-0.27-0.95-1.35
Diluted normalized net income/share-2.4-10640.0-0.27-0.95-1.35
Diluted weighted shares outstanding11 M1,854 M37 M45 M10 M
GainOnSaleOfSecurity-1 M-3 M
GeneralAndAdministrativeExpense6 M6 M9 M8 M6 M
Gross operating profit120000.0
ImpairmentOfCapitalAssets6 M249000.0
Income before tax-26 M-20 M-10 M-52 M-15 M
Income taxes-648000.0-10 M-2 M
Interest income336000.0-107000.0224000.0246000.0911000.0
InterestExpenseNonOperating1 M
MiscOtherSpecialCharges147000.0
Net income from total operations-26 M-20 M-9 M-42 M-13 M
NetIncomeCommonStockholders-26 M-20 M-9 M-42 M-13 M
NetIncomeContinuousOperations-26 M-20 M-9 M-42 M-13 M
NetNonOperatingInterestIncomeExpense-1 M-107000.0224000.0246000.0911000.0
Normalized income-19 M-9 M-10 M-28 M-17 M
Operating income-24 M-11 M-15 M-18 M-13 M
Operating income before depreciation (EBITDA)-22 M-19 M-10 M-52 M-15 M
OperatingExpense24 M11 M15 M18 M13 M
Other income net-1 M3 M-5 M34 M3 M
OtherGandA6 M6 M9 M8 M6 M
OtherImpairmentOfCapitalAssets249000.034 M
OtherOperatingExpenses1 M
OtherWriteOff264000.0
Research & development expense16 M4 M6 M10 M5 M
ResearchExpense16 M4 M6 M10 M5 M
SalariesAndWages3 M2 M
Selling Gen & administrative expense8 M7 M10 M8 M7 M
SellingAndMarketingExpense3 M1 M518000.0661000.0252000.0
Special income/charges-6 M-249000.0
Total Income available for interest expense (EBIT)-24 M-20 M-10 M-52 M-15 M
Total net income-26 M-20 M-9 M-42 M-13 M
Total ordinary shares9 M9 M9 M9 M9 M
Total revenues196000.0
TotalExpenses-24 M-11 M15 M18 M13 M
TotalRevenue196000.0
WriteOff413000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University